The groundbreaking approach of the medication represents a exciting development in the management of diabetes mellitus type 2. Unlike existing drugs, tirzepatide targets dual pathways – glucagon-like peptide-1 https://tirzepatidepeptide119745.ampedpages.com/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment-69055275